Stephenson Cancer Center

What Stephenson Cancer Center does

Stephenson Cancer Center is the only National Cancer Institute (NCI)-Designated Cancer Center in Oklahoma and one of 73 nationally. Operated as a wholly owned subsidiary of OU Health — the University of Oklahoma's public academic health system — it delivers comprehensive cancer care, research, and clinical trial services to adult and pediatric patients across Oklahoma's 77 counties from its main campus in Oklahoma City and expanded locations in Tulsa (Hillcrest), Norman, and McAlester.

The center's clinical portfolio spans autologous and allogeneic blood and marrow transplantation (the only program in the state performing allogeneic transplants), CAR-T cell therapy, chemotherapy and infusion, radiation therapy, surgical oncology across multiple subspecialties, proton therapy, and theranostics. It is the only facility in Oklahoma offering Foundation for the Accreditation of Cellular Therapy (FACT)-accredited cellular therapy, a National Marrow Donor Program-designated transplant and donor collection center, and a member of the NCI National Clinical Trials Network (NCTN), BMT CTN, CIBMTR, SWOG, Alliance for Clinical Trials in Oncology, Sarah Cannon Transplant and Cellular Therapy Network, and the Children's Oncology Group. Diagnostic technology includes a Siemens MAGNETOM Terra 7 Tesla MRI (only one in Oklahoma) and a NAEOTOM Alpha photon-counting CT scanner under a 10-year Siemens Healthineers Value Partnership. Investigative research includes Phase 1/2 trials of OKN-007, an investigational glioblastoma drug developed with OMRF.

Revenue is generated through clinical care services billed via insurance, Medicare, Medicaid, and self-pay, supplemented by clinical trial funding, NIH grants, and academic/research revenue streams consolidated under OU Health (which reports system-wide annual revenue trending toward $3.6 billion across all centers). The customer base comprises adult and pediatric oncology patients (including clinical trial participants) across Oklahoma and the surrounding region, with the center now treating 1 in 4 Oklahomans with cancer — up from 1 in 6 — and conducting 100+ stem cell transplants annually.

Name

Stephenson Cancer Center

Legal name

OU Health

Website

https://ouhealth.com

Company type

Private

Founded year

2022

Operating status

Operating

Headcount range

1,001–5,000 employees

Short description

Stephenson Cancer Center is Oklahoma's only NCI-Designated Cancer Center and a subsidiary of OU Health, providing comprehensive adult and pediatric oncology care, blood and marrow transplantation, CAR-T therapy, radiation, surgical oncology, proton therapy, theranostics, and clinical trials across Oklahoma from its Oklahoma City headquarters and regional sites in Tulsa, Norman, and McAlester.

Ownership category

akta.pro rank

Product category

Oncology Services

NAICS

Offices of Physicians (62111), Specialty (except Psychiatric and Substance Abuse) Hospitals (622310), Ambulatory Health Care Services (621)

SIC

Services-Health Services (8000), Services-Offices & Clinics Of Doctors Of Medicine (8011)

akta.pro primary industry

Oncology & Cancer Specialty Hospitals (HLAFAHAC)

akta.pro secondary industries

Ambulatory Oncology Centers (Outpatient Chemo/Radiation) (HLAFABAI), Medical Oncology (HLAKAFAB), Neuro-Oncology (HLAKAFAH), Gastrointestinal Oncology (HLAKAFAK)

Keywords

• Cancer treatment services
• Oncology clinical trials
• Stem cell transplantation
• Radiation therapy
• Surgical oncology

Headquarters

HQ city

Oklahoma City

HQ country

United States

HQ region

North America

Offices5 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure

Revenue model

1. Clinical Care Services: Revenue generated from providing cancer treatment services including chemotherapy, radiation therapy, surgery, stem cell transplants, and cellular therapies. Billed through insurance, Medicare, Medicaid, and self-pay based on services provided.
2. Clinical Trials: Revenue from conducting clinical trials, potentially including pharmaceutical company partnerships and NIH grants for research
3. Academic Health System Revenue: Part of OU Health's academic health system generating revenue from patient care, research funding, and education programs. Annual revenue trending toward $3.6 billion.

Pricing tiers

Go-to-market motion1 record

Distribution channels3 records

Marketing channels4 records

Core offering

Stephenson Cancer Center provides comprehensive cancer treatment services including chemotherapy, radiation therapy, surgical oncology, blood and marrow transplantation (autologous and allogeneic), CAR-T cell therapy, proton therapy, and theranostics. As the only NCI-Designated Cancer Center in Oklahoma and one of 73 in the nation, it also delivers Phase I clinical trials, investigational drug research (including OKN-007 for glioblastoma), and multidisciplinary supportive care for cancer patients across Oklahoma.

Product overview

Stephenson Cancer Center is the only National Cancer Institute (NCI)-Designated Cancer Center in Oklahoma and part of OU Health's academic health system. It offers a comprehensive portfolio of cancer treatment services organized as distinct clinical programs: Blood and Marrow Transplant Therapy (with autologous and allogeneic transplants including CAR-T Cell Therapy), medical oncology (Chemotherapy & Infusion), Radiation Therapy, Surgical Oncology (spanning breast, colon/rectal, hepatobiliary/pancreas/GI, lung/thoracic, soft tissue/skin, and head/neck cancers), Proton Therapy, Theranostics, and Cancer Clinical Trials (including Phase I trials). The center also provides Cancer Supportive Care and Cancer Navigation Services. For pediatric patients, Oklahoma Children's Hospital Jimmy Everest Center offers dedicated pediatric hematology-oncology services including the state's only pediatric bone marrow transplant program. The programs are interconnected through multidisciplinary tumor boards, Oklahoma's only hematology nurse navigator, and membership in national clinical trial networks.

Differentiator

Problem solved

Functional benefit

Products and services

• Blood and Marrow Transplant Therapy Bone marrow and stem cell transplantation services for cancer patients, including autologous and allogeneic transplants, performed by nationally recognized specialists at an NCI-Designated Cancer Center. Program has been operating since 1982.
• CAR-T Cell Therapy Chimeric antigen receptor T-cell therapy for adults, a cellular therapy allowing additional doses of chemotherapy or radiation without excessive strain on the body, used for leukemia and lymphoma.
• Chemotherapy & Infusion Chemotherapy and infusion services for cancer treatment delivered as part of multidisciplinary oncology care.
• Radiation Therapy Radiation therapy treatments for various cancer types including advanced imaging-guided modalities.
• Surgical Oncology Surgical oncology services including breast cancer surgery, colon and rectal cancer surgery, hepatobiliary/pancreas/GI surgery, lung and thoracic surgery, soft tissue and skin cancer surgery, and head and neck cancer surgery.
• Proton Therapy Advanced proton therapy treatment for cancer patients using targeted particle beam radiation.
• Theranostics Theranostic services combining diagnostics and therapeutics for personalized cancer treatment.
• Cancer Clinical Trials Access to Phase I clinical trials and membership in the National Cancer Institute's National Clinical Trials Network (NCTN), SWOG, Alliance, and other cooperative trial groups.
• Cancer Supportive Care Supportive care services including genetic counseling, nutrition therapy, cancer support groups, palliative care, cancer education workshops, and symptom and pain management.
• Jimmy Everest Center - Pediatric Cancer Treatment Pediatric hematology-oncology services at Oklahoma Children's Hospital, the only facility in Oklahoma offering pediatric bone marrow and stem cell transplantation.
• Cancer Navigation Services Navigation services to guide cancer patients through their treatment journey, including Oklahoma's only hematology nurse navigator.

Quantifiable outcome

• 85% decrease in target lesions for colon cancer patient in clinical trial
• +3 more outcomes

Named customers4 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature6 records

Partnerships

Ten partnerships are on record, tiered core, major and minor.

• Siemens HealthineerscoreTechnology or Integration · 5 December 202310-year Value Partnership to bring latest diagnostic and therapeutic equipment to Oklahoma. Includes MAGNETOM Terra 7 Tesla MRI (only one in Oklahoma, one of five in Midwest), NAEOTOM Alpha CT scanner, and mobile technology for rural communities. Also includes creation of OU Health Sciences Imaging Institute for workforce development and research.
• National Marrow Donor Program (NMDP)coreStrategic or Co-development PartnerNational Marrow Donor Program-designated transplant and donor collection center. Sourcing stem cells for treatment including autologous and allogeneic transplants from peripheral blood, bone marrow, or umbilical cord blood from related and unrelated donors.
• Blood & Bone Marrow Transplant Clinical Trials Network (BMT CTN)majorStrategic or Co-development PartnerCollaborating on research and clinical trials for blood and marrow transplant therapies through this national network.
• Center for International Blood and Marrow Transplant Research (CIBMTR)majorStrategic or Co-development PartnerInternational research collaboration for blood and marrow transplant research and outcomes tracking.
• Southwest Oncology Group (SWOG) Cancer Research NetworkmajorStrategic or Co-development PartnerNational clinical trials network collaborating on cancer research through this Southwest Oncology Group.
• The Alliance for Clinical Trials in OncologymajorStrategic or Co-development PartnerNational alliance of clinical trials network collaborating on cancer research and treatment development.
• Sarah Cannon Transplant and Cellular Therapy NetworkmajorStrategic or Co-development PartnerCollaborating through Sarah Cannon network for transplant and cellular therapy research and treatment development.
• Children's Oncology Group (COG)coreStrategic or Co-development PartnerWorld's largest childhood cancer research organization. Oklahoma Children's Hospital ranks near top for enrollment in COG clinical trials for innovative pediatric cancer treatments.
• Oklahoma Medical Research Foundation (OMRF)coreStrategic or Co-development PartnerDeveloped OKN-007 (Oklahoma Nitrone 007) investigational drug for glioblastoma. Oblato, Inc. acquired rights; Phase 1 and 2 clinical trials being conducted at Stephenson Cancer Center.
• Stillwater Medical CenterminorStrategic or Co-development PartnerPartnership to establish Level II NICU to help families stay closer to home for advanced care.

Scale indicators9 records

Recent moves7 records

Expansion highlights6 records

Broad incumbents

• MD Anderson Cancer Center: University of Texas MD Anderson Cancer Center is the leading NCI-Designated Comprehensive Cancer Center in the U.S. and the most-recognized direct peer given overlapping NCI designation, comprehensive oncology services, clinical trial leadership, and academic medical center affiliation.
• Memorial Sloan Kettering Cancer Center: MSK is one of the nation's elite NCI-Designated Comprehensive Cancer Centers, providing the same multidisciplinary oncology care, translational research, and Phase I clinical trial access that define Stephenson's offering at a national scale.
• Dana-Farber Cancer Institute: Dana-Farber is a Harvard-affiliated NCI-Designated Comprehensive Cancer Center with deep expertise in hematology-oncology, bone marrow transplantation, and cellular therapy — directly comparable to Stephenson's transplant and CAR-T programs.

Direct peers

• H. Lee Moffitt Cancer Center & Research Institute: Moffitt is an NCI-Designated Comprehensive Cancer Center affiliated with the University of South Florida; comparable in scale, mission, and academic structure to Stephenson as a state-affiliated specialty cancer hospital system.
• Fred Hutchinson Cancer Center: Fred Hutch (University of Washington-affiliated) is an NCI-Designated Comprehensive Cancer Center renowned for bone marrow transplantation and cellular therapy research — directly mirroring Stephenson's BMT and CAR-T positioning.
• Winship Cancer Institute of Emory University: Winship is the only NCI-Designated Comprehensive Cancer Center in Georgia, sharing Stephenson's role as the sole in-state NCI center providing comprehensive oncology, clinical trials, and academic cancer care.
• University of Kansas Cancer Center: KU Cancer Center is an NCI-Designated Comprehensive Cancer Center in a neighboring Great Plains state, making it the closest geographic competitor for complex oncology cases and clinical trial enrollment from the regional catchment.
• Siteman Cancer Center at Barnes-Jewish Hospital / Washington University: Siteman is an NCI-Designated Comprehensive Cancer Center affiliated with WashU Medicine in St. Louis, providing overlapping multidisciplinary oncology, Siteman Cancer Network partnerships, and academic cancer research comparable to Stephenson's program.
• Vanderbilt-Ingram Cancer Center: Vanderbilt-Ingram is an NCI-Designated Comprehensive Cancer Center at a major academic medical center, comparable in clinical trial network membership, translational research, and specialty oncology service line depth.
• Harold C. Simmons Comprehensive Cancer Center (UT Southwestern): Simmons is the only NCI-Designated Comprehensive Cancer Center in North Texas, mirroring Stephenson's positioning as the sole NCI center serving its region with comparable academic structure and multidisciplinary oncology services.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks5 records

Key highlights7 records

Customer concentration

• Xx.com/StephensonCC
• Facebookfacebook.com/StephensonCancerCenter
• LinkedInlinkedin.com/company/stephensoncancercenter

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Subsidiaries4 records

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Stephenson Cancer Center